MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cubist Pharmaceuticals Company Profile (NASDAQ:CBST)

Consensus Ratings for Cubist Pharmaceuticals (NASDAQ:CBST) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cubist Pharmaceuticals (NASDAQ:CBST)
Show:
DateFirmActionRatingPrice TargetActions
12/22/2014Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014OppenheimerDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014GabelliDowngradeBuy -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014RBC CapitalDowngradeOutperform -> Sector Perform$84.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014MizuhoDowngradeBuy -> Neutral$97.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014Jefferies GroupDowngradeBuy -> Hold$88.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014SunTrustDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Credit SuisseDowngradeOutperform -> Neutral$77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014WedbushInitiated CoverageNeutral$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014JMP SecuritiesDowngradeOutperform -> Market Perform$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2014AegisReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 4/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha